Cadmium disrupts signaling of the hypoxia-inducible (HIF) and transforming growth factor (TGF-β) pathways in placental JEG-3 trophoblast cells via reactive oxygen species
Adebambo, O. A., Shea, D., & Fry, R. C. (2018, February 9). Toxicology and Applied Pharmacology, Vol. 342, pp. 108–115.
author keywords: Reactive oxygen species; Hypoxia; Placentation; Growth factor; Gene expression; Cadmium
MeSH headings : Cadmium / toxicity; Cell Line, Tumor; Dose-Response Relationship, Drug; Female; Humans; Hypoxia-Inducible Factor 1, alpha Subunit / antagonists & inhibitors; Hypoxia-Inducible Factor 1, alpha Subunit / metabolism; Placenta / cytology; Placenta / drug effects; Placenta / metabolism; Pregnancy; Reactive Oxygen Species / metabolism; Signal Transduction / drug effects; Signal Transduction / physiology; Transforming Growth Factor beta / antagonists & inhibitors; Transforming Growth Factor beta / metabolism; Trophoblasts / drug effects; Trophoblasts / metabolism
topics (OpenAlex): Pregnancy and preeclampsia studies; Heavy Metal Exposure and Toxicity; Birth, Development, and Health
TL;DR:
Treatment of placental trophoblast cells with Cd results in increased production of ROSs that disrupt placentation pathways involved in disease pathogenesis, and co‐occurrence of Cd with other toxic metals, particularly arsenic, may induce detrimental health effects that are currently underestimated when analyzed as single metals.
(via
Semantic Scholar)
UN Sustainable Development Goal Categories
Sources: Web Of Science, ORCID, NC State University Libraries